PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Overview Fund Activity
Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

65 hedge funds and large institutions have $63.8M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 12 closing their positions.

Holders
65
Holders Change
-3
Holders Change %
-4.41%
% of All Funds
1.05%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
11
Increased
20
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
1
Soleus Capital Management
Connecticut
$2.11M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$5.08M
3
FCMV
3
Foresite Capital Management V
California
$17M
4
Walleye Capital
4
Walleye Capital
New York
$451K
5
C
5
Chescapmanager
Maryland
$861K

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$3.69M
3
FLSM
3
Frazier Life Sciences Management
California
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$0
5
TCM
5
Tang Capital Management
California
$57K
Name Market Value Shares Shares
Change 		Shares
Change %
SOW
76
State of Wyoming
Wyoming
– – -50 Closed
CFGS
77
Concourse Financial Group Securities
Alabama
– – – –
Nisa Investment Advisors
78
Nisa Investment Advisors
Missouri
$0 138 +138 New
1 2 3
4